Surge in Call Options: Sun Pharmaceutical Industries Sees 6,085 Contracts at ₹1700 Strike

Sun Pharmaceutical Industries Ltd has emerged as one of the most active stocks today, particularly in the options market. The company, a significant player in the Pharmaceuticals & Biotechnology sector, has seen substantial trading activity in call options set to expire on July 31, 2025.
Notably, the call option with a strike price of 1700 recorded the highest trading volume, with 6,085 contracts exchanged and a turnover of approximately Rs 600.80 lakhs. Following closely, the 1720 strike price option saw 5,853 contracts traded, generating a turnover of Rs 376.11 lakhs. The 1740 strike price option also attracted attention, with 3,835 contracts traded and a turnover of Rs 166.57 lakhs. The underlying value of SUNPHARMA stands at Rs 1689.80, with open interest levels at 5,485, 6,447, and 3,048 for the respective strike prices.

In terms of performance, Sun Pharmaceutical has outperformed its sector by 0.34% today, marking a consecutive gain over the last three days with a total return of 1.83%. The stock is currently trading above its 5-day and 20-day moving averages, although it remains below the longer-term averages of 50, 100, and 200 days. However, there has been a notable decline in investor participation, with delivery volume dropping by 39.41% compared to the 5-day average.

Overall, Sun Pharmaceutical Industries Ltd continues to demonstrate significant activity in the market, reflecting its strong position within the large-cap segment of the industry.